Enzo Biochem (ENZ)
0.6531 -0.0049 (-0.74%) 01/24/25 [NYSE]
0.6203 x 1,300 1.3000 x 100
Realtime by (Cboe BZX)
0.6203 x 1,300 1.3000 x 100
Realtime 0.6444 -0.0087 (-) 01/24/25
for Fri, Jan 24th, 2025
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
Sales | 7,526 | 8,022 | 8,553 | 7,806 | 8,959 |
Cost of Goods | 4,306 | 4,289 | 4,329 | 4,351 | 5,814 |
Gross Profit | 3,220 | 3,733 | 4,224 | 3,455 | 3,145 |
Operating Expenses | 6,187 | 6,065 | 6,738 | 9,282 | 11,169 |
Operating Income | -2,661 | -2,043 | -2,185 | -5,476 | -7,210 |
Other Income | 1,513 | -88 | 1,322 | -199 | -1,669 |
Pre-tax Income | -1,148 | -2,131 | -863 | -5,675 | -8,879 |
Net Income Continuous | -1,148 | -2,131 | -863 | -5,675 | -8,879 |
Net Income Discontinuous | -12,233 | -889 | -2,198 | -941 | 66,309 |
Net Income | $-13,381 | $-3,020 | $-3,061 | $-6,616 | $57,430 |
EPS Basic Total Ops | -0.26 | -0.06 | -0.06 | -0.13 | 1.17 |
EPS Basic Continuous Ops | -0.02 | -0.04 | -0.02 | -0.11 | -0.18 |
EPS Basic Discontinuous Ops | -0.24 | -0.02 | -0.04 | -0.02 | 1.35 |
EPS Diluted Total Ops | -0.26 | -0.06 | -0.06 | -0.13 | 1.17 |
EPS Diluted Continuous Ops | -0.02 | -0.04 | -0.02 | -0.11 | -0.18 |
EPS Diluted Discontinuous Ops | -0.24 | -0.02 | -0.04 | -0.02 | 1.35 |
EPS Diluted Before Non-Recurring Items | N/A | -0.03 | 0.00 | -0.11 | N/A |
EBITDA(a) | $-2,263 | $-1,706 | $-1,918 | $-5,206 | $-6,604 |